» Authors » Aaron T Brah

Aaron T Brah

Explore the profile of Aaron T Brah including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 19
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Saldarriaga E, Hauber B, Barthold D, Brah A, Tran J, Marconi V, et al.
BMC Infect Dis . 2025 Feb; 25(1):237. PMID: 39972307
Background: Long-acting antiretroviral therapy (LA-ART) is an emerging alternative to daily oral ART pills that may improve HIV treatment adherence. We studied preference heterogeneity for LA-ART among people with HIV...
2.
Graham S, Barthold D, Hauber B, Brah A, Saldarriaga E, Collier A, et al.
J Int AIDS Soc . 2023 Jul; 26 Suppl 2:e26099. PMID: 37439051
Introduction: Recent advances in long-acting antiretroviral therapy (LA-ART) could provide new options for HIV treatment and reduce adherence barriers, if regimens are acceptable to patients. We elicited preferences for key...
3.
Barthold D, Saldarriaga E, Brah A, Hauber B, Banerjee P, Fuller S, et al.
AIDS . 2023 Jun; 37(10):1545-1553. PMID: 37289570
Objective: To examine the characteristics of people with HIV (PWH) who prefer remaining on daily oral antiretroviral therapy (ART), rather than switching to long-acting ART (LA-ART). Design: Building upon a...
4.
Barthold D, Brah A, Graham S, Simoni J, Hauber B
Patient . 2022 May; 15(5):513-520. PMID: 35595961
Background And Objective: Development of clear and effective discrete-choice experiment surveys is an important step toward ensuring accurate and usable preference results. Pretest interviews and pilot testing are common in...
5.
Brah A, Barthold D, Hauber B, Collier A, Ho R, Marconi V, et al.
AIDS Res Ther . 2022 Feb; 19(1):13. PMID: 35216610
Introduction: Patient preferences for long-acting antiretroviral therapies (LA-ART) should inform development of regimens with optimal adherence and acceptability. We describe a systematic process used to identify attributes and levels for...